http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2610960-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2006-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f87c7f720d4a59975613874c4b439995 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56ab9b72f6ea77dda235e24db4532f6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0663bbab2645f03103281dbbea679555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1ea5ebfdccc40008e72b5b5085a8c0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bd8fc6d886f5f9b393ede8084341bc5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c4ec716ae0e694da4b01a4181452795 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33aa401f736c46fb0acd0f3329a4c5ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a387efc401305898036bbbcfb030ad7f |
| publicationDate | 2006-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2610960-A1 |
| titleOfInvention | Expression profiles of peripheral blood mononuclear cells for inflammatory bowel diseases |
| abstract | The present invention is directed to the identification of PBMC- and IBD-associated biomarkers that may be used to diagnose inflammatory bowel disease, and optionally, distinguish between PBMCs isolated from a patient with Crohn's disease and PBMCs isolated from a patient with ulcerative colitis. The present invention is further directed to methods of screening, including high throughput methods of screening, for regulatory agents capable of regulating the activity of PBMC- and IBD-associated biomarkers. Provided are compositions of PBMC- and IBD-associated biomarkers, including regulatory agents of at least one PBMC- and IBD-associated biomarker for methods of diagnosis, prognosis, therapeutic intervention and prevention of an inflammatory bowel disease, e.g., Crohn's disease and ulcerative colitis. Moreover, the present invention is also directed to methods that can be used to assess the efficacy of test compounds and therapies in the treatment inflammatory bowel disease, i.e., Crohn's disease or ulcerative colitis. |
| priorityDate | 2005-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 579.